Real-World Effects and Utilisation Patterns of Elexacaftor, Tezacaftor, and Ivacaftor Combination Therapy (ELX/TEZ/IVA) in Patients with Cystic Fibrosis (CF)

15/09/2021
23/06/2026
EU PAS number:
EUPAS43022
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

ELX-TEZ-IVA PASS Protocol_Version 2.0_redacted

English (674.84 KB - PDF) View document
Study results
Study report
Abstract of study report

ELX_TEZ_IVA_PASS_FinalAbstract.pdf

English (266.25 KB - PDF) View document
Other information